Japan’s Daiichi Sankyo owned major pharma company Ranbaxy Laboratories has posted a steep drop in net profit for the period Q1 (ending Mar 11) of the current fiscal (FY11). During the said quarter, net profit declines 68.4% to Rs 304.39 crores in comparison to Rs 201.3 crores of Q1 (ending Mar 10) of previous year (FY10). Ranbaxy Laboratories Limited is India’s largest pharmaceutical company. Incorporated in 1961, Ranbaxy exports its products to 125 countries with ground operations in 46 and manufacturing facilities in seven countries. The company went public in 1973 and Japanese pharmaceutical company Daiichi Sankyo gained majority control in 2008.
The company has informed the share market (BSE/NSE) that the total income/sales down to Rs 2,147 crore in Q1 (ending Mar 2011) of the current fiscal (FY11) when compared with the same quarter Q1 (ending Mar 2010) of previous year (FY10). Total income was Rs 2,485 crores in last year’s quarter Q1.
Ranbaxy’s sales from overseas markets, which account for the bulk of the revenue, were down 19.4% to Rs 1,697.9 crore. Its sales from the domestic market rose 18.5% to Rs 448.91 crore.
Share’s Data :-
BSE Code : 500359
Mkt. Cap : Rs 18,925.07 Crores
Ranbaxy Laboratories Ltd. share’s CMP is Rs 449.10 on 10th May 2011.
Stay tuned to BelltheBull Blog for more news on Ranbaxy Laboratories Limited !Google+